The structure of the core NuRD repression complex provides insights into its interaction with chromatin
Abstract
The NuRD complex is a multi-protein transcriptional corepressor that couples histone deacetylase and ATP-dependent chromatin remodelling activities. The complex regulates the higher-order structure of chromatin, and has important roles in the regulation of gene expression, DNA damage repair and cell differentiation. HDACs 1 and 2 are recruited by the MTA1 corepressor to form the catalytic core of the complex. The histone chaperone protein RBBP4, has previously been shown to bind to the carboxy-terminal tail of MTA1. We show that MTA1 recruits a second copy of RBBP4. The crystal structure reveals an extensive interface between MTA1 and RBBP4. An EM structure, supported by SAXS and crosslinking, reveals the architecture of the dimeric HDAC1:MTA1:RBBP4 assembly which forms the core of the NuRD complex. We find evidence that in this complex RBBP4 mediates interaction with histone H3 tails, but not histone H4, suggesting a mechanism for recruitment of the NuRD complex to chromatin.
https://doi.org/10.7554/eLife.13941.001eLife digest
The correct regulation of our genes is essential for life. Genes are actively switched on or off through the action of assemblies of proteins that act together as molecular machines. Some of these machines alter the way that DNA is packaged inside cells. Packaged DNA – called chromatin – consists of DNA wrapped around proteins called histones, which together form structures called nucleosomes. Changing how tightly nucleosomes are packed together can alter whether a gene is active: tighter packing makes it harder to access the genes in that stretch of DNA and therefore inactivates them.
In humans, an assembly of proteins called the NuRD complex makes chromatin more compact by removing acetyl groups from nucleosomes. This complex is important for early development and for the stability and repair of our genes. Three proteins make up its core: HDAC1, which removes the acetyl group from the nucleosome; MTA1, which acts as a scaffold to hold the complex together; and RBBP4, which enables the complex to interact with nucleosomes.
Understanding how protein complexes are assembled tells us a lot about how they work. Millard et al. have therefore used a number of structural techniques to investigate the three-dimensional architecture of the three core proteins in the NuRD complex. The resulting structures have revealed how the HDAC1, MTA1 and RBBP4 proteins interact to influence how the complex is recruited to nucleosomes. The next step will be to assemble all the remaining proteins of the NuRD complex to understand its architecture as a whole.
https://doi.org/10.7554/eLife.13941.002Introduction
The nucleosome remodelling and deacetylase (NuRD) complex is one of at least five corepressor complexes that recruits and activates class I histone deacetylase (HDACs) enzymes and directs their activity to chromatin (Bantscheff et al., 2011; Guenther et al., 2000; Humphrey et al., 2001; Itoh et al., 2015; Kelly and Cowley, 2013; Laherty et al., 1997; Oberoi et al., 2011; Vermaak et al., 1999; Watson et al., 2012; Wen et al., 2000; Xue et al., 1998; Zhang et al., 1999). The NuRD complex plays a major role in the regulation of gene expression as well as being involved in chromatin organization, DNA damage repair, and genomic stability (Denslow and Wade, 2007; Lai and Wade, 2011). The NuRD complex is composed of six proteins, each with several isoforms: HDAC1/2, MTA1/2/3, RBBP4/7, P66α/β, MBD2/3, and CHD3/4 (Allen et al., 2013). The complex is special in its ability to exhibit dual enzymatic functionality through its HDAC (protein deacetylation) and ATPase (chromatin remodelling) domains.
Histone Deacetylases (HDACs) are important regulators of transcription that are involved in silencing genes and/or priming them for successive rounds of transcription (Micelli and Rastelli, 2015; Verdin and Ott, 2014; Wang et al., 2009). HDACs act by removing the acetyl groups from modified lysine residues on histone tails and other non-histone proteins. These enzymes have been shown to be overexpressed in various cancer tissues and several inhibitors against these enzymes are currently used in the clinic as anti-cancer therapeutics (Falkenberg and Johnstone, 2014; Marks and Xu, 2009).
Metastasis-associated protein 1 (MTA1) (and its closely related homologues MTA2 and 3) are up-regulated in various cancer tissues (Fujita et al., 2003; Li et al., 2012; Sen et al., 2014; Toh et al., 1994). They serve as scaffold proteins for the assembly of the NuRD complex. The amino-terminal region contains four established domains: an amino-terminal BAH domain, followed by ELM2 and SANT domains, and a GATA-like zinc finger domain towards the centre of the protein (Manavathi and Kumar, 2007; Millard et al., 2014). The ELM2 domain has been shown by X-ray crystallography to mediate dimerization of the complex and, in conjunction with the SANT domain, recruits HDAC1 & 2 (Millard et al., 2013). The structure and function of the MTA-BAH and zinc finger domains remain to be determined. The carboxy-termini of the MTA proteins are much more diverse and structure predictions suggest that much of the protein is intrinsically disordered. The exception is at the very carboxy-terminus of MTA1 and MTA2 where a short helix has been shown to mediate interaction with RBBP4/7 (Alqarni et al., 2014). A binding site for CHD4 has also been identified in this region, but has not been structurally characterised (Nair et al., 2013).
RBBP4 and RBBP7 are homologous (92% identical) histone binding proteins (also known as RbAp48 and RbAp46) that have been shown to be core components of the NuRD complex. These proteins are unusual in that they are present in multiple complexes including other class I HDAC corepressors such as the Sin3A and PRC2 complexes (Ciferri et al., 2012; Kuzmichev, 2002; Zhang et al., 1997). These proteins have also been reported to have roles in nucleosome assembly: RBBP4, along with sNASP and Asf1 forms a multi chaperone complex whose function is to maintain a supply of newly synthesized histone H3 and H4 proteins under replicative stress (Groth et al., 2005). RBBP4 has also been found to be a subunit of the chromatin-assembly factor-1 (CAF-1) complex whose function is to initiate nucleosome assembly by assembling histones H3 and H4 onto newly synthesized DNA (Parthun et al., 1996; Verreault et al., 1996). In addition, RBBP7 has been found to be an essential subunit of the HAT1 histone-acetyltransferase complex, which acetylates newly synthesized histone proteins (Verreault et al., 1998). RBBP4 and RBBP7 have been shown to interact directly with histone H3 and H4 tails through two distinct binding sites and therefore have the potential to act as chromatin recruitment modules (Murzina et al., 2008; Nowak et al., 2011; Schmitges et al., 2011; Song et al., 2008; Zhang et al., 2013).
RBBP4 and RBBP7 are WD40 domain proteins with a characteristic seven bladed β-propeller structure (Xu and Min, 2011). RBBP4/7 interacts with histone H3 through a binding site on the ‘top’ face of the protein (Schmitges et al., 2011). A particular feature of the RBBP4/7 WD40 domain is an amino-terminal helix of 30 residues that forms an extension to the β-propeller domain. A groove that is formed adjacent to this helix mediates interaction with the amino-terminus of histone H4 (Murzina et al., 2008). Interestingly, the extreme carboxy-terminus of MTA1 (residues 671–690) has been shown to interact with RBBP4/7 in this groove, making very similar contacts to those made by histone H4 (Alqarni et al., 2014).
In this study, we have identified a second RBBP4 recruitment site within MTA1 that is positioned near the centre of the corepressor. This site shows some sequence homology to the previously characterised carboxy-terminal recruitment site, but is considerably more extensive. We show that both sites within the MTA1 monomer are capable of independently recruiting RBBP4 proteins such that the HDAC1:MTA1 dimer recruits four molecules of RBBP4 to the NuRD complex. The crystal structure of this central recruitment site reveals an extensive interface that requires some structural rearrangement within RBBP4. Small angle X-ray scattering (SAXS) and single-particle negative-stain electron microscopy (EM) reveal the architecture of the core NuRD complex. RBBP4 proteins are tethered to the HDAC1 dimer by MTA1 forming an elongated zig-zag conformation. We show that when in complex with MTA1, RBBP4 is able to interact with histone H3, but not histone H4 suggesting a mechanism for recruitment of the NuRD complex to chromatin.
Results
The MTA1 dimer recruits four RBBP4 subunits to the NuRD complex
During purifications of various HDAC1:MTA1 complexes expressed in mammalian cells, we observed an endogenous protein of c. 50kDa co-purifying with these complexes. Peptide mass spectrometry identified this protein as being the WD40 protein RBBP4 and/or RBBP7. The interaction between RBBP4/7 and the carboxy-terminus of MTA1 (residues 670–691) is well characterised and an atomic resolution structure of a 22 residue MTA1 peptide bound to RBBP4 has been previously solved by X-ray crystallography (Alqarni et al., 2014). However, we were intrigued to find that RBBP4/7 was recruited to constructs that lacked this well-characterised interaction domain. This appears to fit with previous findings that indicated that RBBP4/7 may interact with a region containing the MTA1 zinc finger domain and adjacent sequences (Roche et al., 2008).
These findings suggested that two regions of MTA1 are able to mediate interaction with RBBP4. What remained unclear was whether these two regions collaborate to bind to a single RBBP4 protein or whether there are two separate binding sites that result in two RBBP4 proteins binding to MTA1.
To define the biologically relevant regions of MTA1 that recruit RBBP4/7, various fragments of MTA1, and full-length HDAC1, were co-transfected into mammalian cells (Figures 1a and 1b). These complexes were purified utilising a FLAG tag on MTA1 and we examined the apparent stoichiometry for the recruitment of endogenous RBBP4/7 to these complexes using gel densitometry (Figure 1c). Importantly, the MTA1-B construct spanning residues 162–546 appears to pull down a stoichiometric 1:1 ratio of HDAC1:RBBP4/7 suggesting that this region is sufficient to form a bona fide interface with RBBP4/7. Interesting a construct spanning residues 162–715 (MTA1-C) pulls down a supra-stoichiometric ratio of 1:1.5 of HDAC1:RBBP4/7. This implies that there may be two RBBP4/7 proteins associated with MTA1 (Figure 1c).
To confirm the stoichiometry of the complex we co-expressed RBBP4 with different length MTA1 fragments extending from the zinc finger domain. The resulting complexes were purified by gel filtration and analysed with Multi-Angle Light Scattering (MALS) to determine the overall molecular weight. The longer fragment of MTA1-D (residues 390–715) in complex with RBBP4 was shown to have a molecular weight of 130 kDa (Figures 1d and 1f; see also Figure 1—figure supplement 1). This closely fits with the predicted molecular weight (131 kDa) of a 1:2 stoichiometry of one MTA1 fragment bound to two RBBP4 proteins. The shorter MTA1-R1 fragment (residues 464–546) in complex with RBBP4 was determined to have a molecular weight of 54 kDa which is close to the predicted molecular weight of 58 kDa for the 1:1 complex (Figures 1e and 1g; see also Figure 1—figure supplement 1).
It is clear that these experiments support a model in which two RBBP4 proteins are recruited by MTA1 to the NuRD complex. Since there are two recruitment sites for RBBP4 we have called these R1 (residues 464–546) and R2 (residues 670–691).
An extensive interface is formed between RBBP4 and the R1 domain of MTA1
To understand the nature of the interface between the R1 domain from MTA1 and RBBP4 we co-expressed and purified a complex between MTA1-R1 (residues 464–546) and full-length RBBP4. The complex was affinity purified on Flag resin using an amino-terminal tag on MTA1 before being cleaved from the resin and gel filtrated. The complex was concentrated to 10 mg/ml and small crystals were obtained. X-ray diffraction data were collected to 3.2 Å and the structure solved by molecular replacement using the structure of RBBP4 (pdb code: 4PC0). The density for MTA1 was remarkably clear and the structure of the complex was built through multiple rounds of refinement (Figure 1—figure supplement 1).
The seven bladed beta-propeller fold of RBBP4 is largely unchanged by the binding of MTA1-R1. The first 10 residues of RBBP4 are unstructured, and similar to previous structures of RBBP4/7, the 14 carboxy-terminal residues are not observed. A notable difference in this structure is the stabilisation of a loop that supports binding of MTA1 (see below).
The interface between MTA1-R1 and RBBP4 is extensive with a buried surface area of 2,837 Å2 (Figures 2a and 2b, Table 1 and Video 1). MTA1 interacts on the side of the WD40 beta-propeller domain making interactions in three adjacent grooves. Two of these grooves lie on either side of the long amino-terminal helix that forms an extension to the WD40 domain. The contacts made by MTA1 on the surface of RBBP4 can be rationalised into three regions hereafter termed interaction regions A, B and C (Figure 2c). The residues involved in all three interaction regions are conserved in both MTA2 and MTA3 (Figure 2a).
The interaction region A of MTA1 takes the form of an extended strand followed by a short helix (H1) (Figure 2d). The extended strand positions a number of non-polar sidechains into a groove formed between the amino-terminal helix and adjacent strand of RBBP4 that forms part of the ‘linking’ blade of the WD40 domain. This region of MTA1 is held in place by a loop within RBBP4 that is an insert in blade one (residues 104–113) of the WD40 domain. This loop contains five glycine residues and is referred to as the 5G-loop. The 5G-loop adopts an ordered structure on MTA1 binding such that several non-polar residues form an additional interface with MTA1.
Helix H1 of interaction region A is immediately carboxy-terminal to the extended strand and is oriented perpendicularly to it. The helix lies across the base of the long amino-terminal helix of RBBP4 (Figure 2d). The interaction involves four arginine residues forming a zipper-like series of salt bridges with three interdigitating acidic residues on the surface of RBBP4.
The central interaction region B of MTA1 consists of a short helix H2, a structured PYxPI loop and a longer helix H3 (Figure 2e). The helix H2 and PYxPI loop lie in a deep groove between the amino-terminal helix of RBBP4 and the so-called PP-loop (which contains two adjacent prolines). The groove is largely non-polar in character, but the periphery is strongly acidic (Figure 2f). This complements the interacting amino acids in helix H2 and the PYxPI loop of MTA1. Helix H3 interacts with two phenylalanines on RBBP4; F30 on the surface of the amino-terminal helix and F105 with the 5G-loop.
The final interaction region C is composed primarily of helix H4 which binds in a third groove on the surface of RBBP4 on the far side of the PP-loop (Figure 2g). The interaction is primarily non-polar in character.
Architecture of the core NuRD complex
Bioinformatic analysis of MTA1 indicates that there are only short regions of predicted disorder between the ELM2-SANT domain and the R1 domain. This suggested that the MTA1:HDAC1:RBBP4 proteins might form a structural core to the NuRD complex with a fixed arrangement of subunits. We have used a combination of small angle X-ray scattering (SAXS), single-particle negative-stain electron microscopy (EM) and chemical crosslinking to determine the architecture of this core complex. For the SAXS analysis, we compared the scattering profile and the calculated envelope of the HDAC1:MTA1-A (residues 162–354) complex with that of the MTA1-B (residues 162–546):HDAC1:RBBP4 complex.
Multi-Angle-Light-Scattering (MALS) confirmed that, as expected from the crystal structure, the HDAC1:MTA1 complex is dimeric, containing two copies of each protein (Figure 3—figure supplement 1). The SAXS data for the complex are consistent with minimal aggregation (linear I(q) at low q). A theoretical scattering profile was calculated from the crystal structure of HDAC1:MTA1 (Millard et al., 2013) and this was in good agreement with the experimental data with a χ2 function of 1.54. Furthermore, the crystal structure of the HDAC1:MTA1 dimer was a convincing fit to the averaged ab initio molecular envelope generated from the SAXS curve (Figures 3a, 3b and 3c).
-
Figure 3—source data 1
- https://doi.org/10.7554/eLife.13941.009
MALS analysis of the MTA1:HDAC1:RBBP4 complex showed that this ensemble is also dimeric, with the experimental mass of 300 kDa closely matching the theoretical mass (294 kDa) (Figure 3—figure supplement 2). The ab initio molecular envelope generated from the SAXS curve in the lowest symmetry mode (P1) suggests that the core NuRD complex has an elongated architecture (Figures 3d,e and f). Although no symmetry was imposed, the envelope has an approximate two-fold symmetry consistent with a dimeric complex. We fitted the HDAC1:MTA1 dimer in the centre of the envelope such that the two-fold axis of symmetry matched the approximate symmetry of the envelope (Figure 3f). This left two 'lobes' to the envelope that were of sufficient volume to contain the structure of the MTA1-R1:RBBP4 complex and additional volume for the zinc-finger domain that forms a link between the two X-ray structures.
Our crosslinking data indicated that one face of HDAC1 could readily form crosslinks with one face of RBBP4, suggesting a particular relative orientation of the two proteins in the core complex. We orientated the MTA1-R1:RBBP4 structure within the two 'lobes' so as to satisfy the largest number of crosslinks (Figure 3g and Figure 3—source data 1). The crosslinks that could not be satisfied are likely to derive from higher order oligomers of the core complex. A theoretical scattering profile was calculated from the docked model of the MTA1:HDAC1:RBBP4 complex. This showed reasonable agreement with the experimental data with a χ2 function of 2.16.
To further investigate the architecture of the MTA1:HDAC1:RBBP4 ensemble we used negative stain EM to determine a low resolution structure of the core NuRD complex, crosslinked with glutaraldehyde to maintain integrity. A 60 Å Gaussian low-pass-filtered, initial model was generated based on the model derived from the SAXS, crosslinking and crystal structure data. This initial model was refined against 17,841 semi-automatically picked particles (Figure 4a). The resulting EM envelope showed that RBBP4 and HDAC1 form a closer association than predicted in the SAXS model. The HDAC1:MTA1 and MTA1-R1:RBBP4 structures fitted well within this envelope. In their new position the RBBP4 domains are tipped by 30° such that they are approximately parallel to each other and propagate the symmetry of the HDAC1:MTA1 dimer. This position fits well with the cross-linking data. A 30 Å filtered model was then generated, based on the new position of RBBP4, and refined further to produce a 19 Å EM structure using the FSC criterion with a cutoff of 0.143 (Figure 4b,c).
The resulting EM envelope, along with the fitted crystal structures, clearly shows the HDAC1:MTA1 central dimer and a detailed outline of the RBBP4 lobes (Figure 4c and Video 2). The model suggests a number of contacts between RBBP4 and HDAC1 that determine the relative orientation. The active sites of both HDACs are on the convex side of the complex and are exposed to enable substrate binding. Extra density surrounding the dimerization domain of MTA1 may indicate the position of the MTA1 zinc finger domains and/or the tails of HDAC1 and RBBP4. The reference-free 2D class averages fit well with the model of the MTA1:HDAC1:RBBP4 complex and with the re-projections of the EM class averages (Figure 4d and Figure 4—figure supplement 1).
Comparison with other RBBP4 complexes
Since we have established that two copies of the RBBP4 protein are recruited to MTA1, we compared the amino-terminal recruitment domain, R1, with the previously identified carboxy-terminal domain, R2. Sequence alignment show that a stretch of c.35 residues is highly similar between the two recruitment regions (Figure 5a). These include the amino terminal strand, helices H1 & H2 and the PYxPI loop. A previous structure of the R2 domain in complex with RBBP4 included helix H2 and the PYxPI loop (22 residues) (Alqarni et al., 2014). Comparison of this structure with that of the equivalent region of the R1 domain (region B in the description above) shows a highly similar mode of binding to RBBP4 (Figure 5b). Indeed, the path of the mainchain from P492 to I503 is essentially identical. The sidechains A495, A496 and R497 in helix H2 and P499, Y500, P502 and I503 in the PYxPI loop mediate key interactions with RBBP4 and are identical in the R2 domain.
The sequence alignment also indicates that the 15 residues preceding helix 2 in the R2 domain have significant sequence similarity to the R1 domain suggesting that the interface between RBBP4 and the R2 domain is likely to be rather more extensive than was observed in the previously reported crystal structure (Figure 5a). We would expect these residues to adopt a structure similar to that seen in interaction region A of the complex between RBBP4 and the R1 domain. An important part of this interface is the 5G-loop that wraps over the top of the amino-terminal strand in the R1 domain. Interestingly this loop adopts a very different conformation in the structure of the MTA1-R2:RBBP4 complex. This alternative orientation may be the consequence of crystal packing interactions.
The surface of RBBP4 that mediates interactions with helix H2 of the R1 and R2 domains of MTA1 has also been shown to mediate interactions with the amino-terminal region of histone H4. Sequence alignment of the MTA1-R1 and -R2 domains with histone H4 shows that there is considerable sequence similarity between these proteins. The structure of histone H4 (residues 27–41) in complex with RBBP4 shows a similar mode of binding to the structure of the bound MTA1-R1 and -R2 domains (Figure 5c) (Murzina et al., 2008). All three proteins bind in the same groove and make similar sidechain contacts with an Alanine-Arginine dipeptide making identical contacts in all three structures (Figures 5b and 5c). Again, sequence comparison suggests that the interface between histone H4 and RBBP4 may be more extensive than seen in the previously reported structure, since the sequence similarity extends at the amino-terminus, into the region corresponding to helix H1 of MTA1-R1.
Interestingly, a fragment of the Polycomb protein Su(z)12 has also been crystallised bound to the central groove of RBBP4. There is little structural or sequence similarity to either the histone H4, MTA1-R1 or MTA1-R2 complexes.
RBBP4 in the NuRD complex binds histone H3 but not histone H4
The previous observation that RBBP4 is able to bind to both histones H3 and H4 suggests that RBBP4 may serve as a common chromatin recruitment module in several chromatin modifying complexes. However, given that the extensive interface between RBBP4 and the R1 domain of MTA1 (and by inference the R2 domain) occludes the binding site for histone H4, we would predict that RBBP4 is no longer able to bind histone H4 in the NuRD complex. However, the histone H3 interaction on RBBP4 is exposed in both the MTA1:RBBP4 binary complex and in the dimeric MTA1:HDAC1:RBBP4 complex. This implies that RBBP4 is likely to play a role in recruiting the NuRD complex to histone H3 tails, but not to histone H4.
To test this, we compared RBBP4 and the MTA1-R1 (residues 464–546):RBBP4 complex in their ability to bind to a peptide array of histone tails, bearing various post-translation modifications. As predicted, we observed that both RBBP4 and the MTA1-R1:RBBP4 complex showed an identical pattern of binding to histone H3 peptides. However, there were significant differences between the binding profiles to histone H4 modified peptides (Figure 6a). The free RBBP4 bound multiple histone H4 tails. In contrast, the MTA1-R1:RBBP4 complex showed only binding to two histone H4 peptides and this was not reproduced in the duplicate arrays (Figure 6—figure supplement 1 and Figure 6—source data 1). Taken together this suggests that when bound to MTA1, RBBP4 binds to histone H3 and not histone H4.
-
Figure 6—source data 1
- https://doi.org/10.7554/eLife.13941.017
Discussion
Here we have investigated the architecture of the core NuRD complex and derived the first model of the arrangement of three major components MTA1/2, HDAC1/2 and RBBP4/7 (Figure 6b). This core complex forms an elongated zig-zag structure as visualised by SAXS and EM, centred around the HDAC1:MTA1 dimerization domain, with RBBP4 ‘lobes’ symmetrically bound to the dimer. We have established that a central section of MTA1 directly recruits RBBP4/7 and brings this subunit into close proximity to HDAC1/2. It is possible that the relative arrangement of HDAC1, MTA1 and RBBP4 may be somewhat different in the holo-NuRD complex. However, the relatively close interaction between HDAC1 and RBBP4, seen in the EM structure, suggests to us that this interface is likely to be present in the full complex.
We have shown that each MTA1 protein recruits two RBBP4/7 molcules to the NuRD complex through the R1 and R2 interaction domains. Since MTA1 is itself a dimer in the complex (Millard et al., 2013) this means that the NuRD complex contains four copies of the RBBP4/7 proteins, which we have confirmed experimentally. Recognisable R1 and R2 interaction domains are present in MTA1 and 2 proteins from fly to man suggesting that the stoichiometry of the NuRD complex is evolutionarily conserved. Our findings fit partially with a previous study of the NuRD complex using label-free mass spectrometry. In this study they also report a 1:2 MTA1:RBBP4/7 stoichiometry, but in contrast to our previous crystal structure of the MTA1:HDAC1 complex, they find a 1:3 HDAC:MTA stoichiometry (Smits et al., 2012).
Alqarni et al. used isothermal titration calorimetry (ITC) to compare the affinity of interaction of the helical region of the R2 domain from MTA1 (656–686) with that of histone H4, which they observed bound in the same groove of RBBP4. The similarity in affinity led them to suggest that there may be competition between MTA1 and histone H4 for binding to RBBP4 (Alqarni et al., 2014). Our findings suggest that there is likely to be a more extensive interface between MTA1-R2 and RBBP4 with an additional helix and beta-strand contributing to the interaction. This is in fact supported by cross-linking data (Kloet et al., 2015). Given this extended interface we suggest that histone H4 is unlikely to be able to compete with either MTA1-R1 or R2 for binding to RBBP4. Indeed, the MTA1-R1:RBBP4 complex appeared highly stable since the resin-bound complex could be washed with 2 M NaCl and 5% triton-X-100 without significant dissociation (data not shown). Taken together our data suggest that once bound to MTA1, the two RBBP4 molcules would remain permanently assembled as a complex.
Since it appears that the histone H4 binding site on RBBP4 is blocked when associated with MTA1 (either R1 or R2) this raises the question as to the role of RBBP4 in the NuRD complex. Importantly, the crystal structure of RBBP4 bound to a histone H3 tail peptide shows that the interaction surface lies on the ‘top’ of the WD40 domain (Schmitges et al., 2011). This site is not blocked by binding to MTA1-R1. Thus RBBP4 would theoretically remain able to bind to histone H3 tails whilst assembled into the NuRD complex. This fits with our experimental data which confirm that the core NuRD complex can bind histone H3 tails but not H4.
Such a model of recruitment to histone H3 is consistent with the architecture of the MTA1:HDAC1:RBBP4 complex since the orientation of RBBP4 relative to the HDAC1:MTA1 dimer means that the histone H3 binding surface of RBBP4 is exposed, albeit close to the interface between HDAC1 and RBBP4, and therefore able to bind the tail of histone H3. Furthermore, the histone recruitment site is sufficiently close to the catalytic site of HDAC1 to allow other histone tails to access the active site.
Interestingly, both RBBP4 and the RBBP4:MTA1 complex show enhanced binding to modified tails of histone H3 lysine 27 (H3K27) (Figure 6a). In particular, H3K27 acetylation and H3K27 methylation appear to promote binding. This would correlate with previous studies that have observed association of the NuRD complex with a specific subset of gene promoters enriched with H3K27me3 (Reynolds et al., 2012). In addition, MBD3, a component of the NuRD complex has been reported to localise at H3K27ac and H3K27me3 enriched sites (Shimbo et al., 2013). RBBP4 may therefore have an important role in directing the NuRD complex to chromatin bearing these modifications.
A number of studies have suggested that RBBP4 and RBBP7 have different functions. Indeed, it has been suggested that they are associated with different complexes. Our structural data suggest that the residues important for mediating interaction with MTA1 are 100% identical and therefore we would expect both RBBP4 and RBBP7 to be associated with the NuRD complex depending upon relative abundance.
Interestingly, in MTA3 the recruitment domain R2 is not present in any species. This suggests that MTA3 only recruits a single RBBP4/7 molcule. Furthermore, a splice variant of MTA1 (MTA1S) does not contain either R1 or R2 domains (Yaguchi et al., 2005). It is intriguing to speculate that these variant NuRD complexes will exhibit different specificities due to different modes of chromatin recruitment. Presumably the presence of four RBBP4 molcules in the NuRD complex increases the avidity for chromatin.
Overall this study provides significant novel insights into the assembly and chromatin recruitment of the core NuRD complex. It establishes the architectural relationship between the histone deacetylase and the RBBP4 chromatin-binding module. Further studies will be required to explore the relative organisation between the HDAC and the CHD3/4 chromatin remodeller.
Materials and methods
Mammalian protein expression
Request a detailed protocolMTA1-A, -B, -C, -D and -E (residues 162–335, 162–546, 162–715, 390–715 and 464–546) were cloned into pcDNA3 vectors containing an amino terminal His10-Flag3 purification tag followed by a TEV protease cleavage site. RBBP4 (residues 1–425) and HDAC1 (residues 1–482) were cloned without affinity tags into the same vectors. Protein constructs were co-transfected into HEK293F suspension-grown cells (Invitrogen) with polyethylenimine (PEI; Sigma) and the cells were harvested after 48 hr as previously described (Nettleship et al., 2014; Portolano et al., 2014; Watson et al., 2012). Cells were lysed in 50 mM Tris-HCl (pH 7.5), 100 mM potassium acetate, 10% v/v glycerol, 0.3% v/v Triton X-100 and Roche Complete Protease Inhibitor (buffer A). The clarified lysate was applied to FLAG resin (Sigma) for 2 hr at 4°C. The resin was washed three times with 50 mM Tris-HCl (pH 7.5), 100 mM potassium acetate and 5% v/v glycerol (buffer B), three times with buffer B containing 200 mM potassium acetate and a further three times with buffer B. The protein was treated with RNase A in buffer B for 1 hr at 4°C before being eluted with TEV overnight into buffer B containing 50 mM potassium acetate. The protein complexes were purified further by gel filtration using a Superdex S200 column into 25 mM Tris-HCl (pH 7.5), 50 mM potassium acetate and 0.5 mM TCEP (GE Healthcare, UK). The purified complex was concentrated to 10 mg/ml.
Gel densitometry
Request a detailed protocolThe intensity of protein bands was determined with ImageJ and the ratio of HDAC1:RBBP4 was plotted using GraphPad Prism.
Size exclusion chromatography with Multi-Angle Light Scattering (MALS)
Request a detailed protocolPurified MTA1:RBBP4, HDAC1:MTA1 and MTA1:HDAC1:RBBP4 complexes that had been gel filtrated were concentrated to 1 mg/ml and reapplied to the Superdex S200 column (GE Healthcare, UK). The mass of each protein complex was calculated immediately on elution with an Optilab T-rEX differential Refractive Index detector coupled to a DAWN HELEOS MALS detector (Wyatt Technology).
Protein crystallisation
Request a detailed protocolDiffracting crystals (25 μm) of MTA1-R1:RBBP4 were grown at 10°C by sitting-drop vapour diffusion against 0.21 M ammonium citrate and 19% PEG 3350. Crystals were frozen in liquid nitrogen using 30% glycerol as a cryoprotectant, initial screening was performed at the Swiss Light Source PX1 (Switzerland), and data were collected at the Diamond microfocus beamline I24 (UK). Data from two crystals were processed with iMOSFLM (Leslie, 2005) and merged using AIMLESS (Evans and Murshudov, 2013) to produce a complete dataset. A unique phase solution was found with RBBP4 (pdb code: 4PC0) (Alqarni et al., 2014) as a search model using PHASER (McCoy et al., 2007) and MTA1 was manually built using multiple rounds of refinement using REFMAC (Murshudov et al., 2011) and COOT (Emsley et al., 2010). The final model contains four copies of residues 9-411 of RBBP4 (chains A, C, E, G) and residues 468-546 of MTA1 (chains B, D, F, H).
Small Angle X-ray Scattering (SAXS)
Request a detailed protocolFor the SAXS experiments HDAC1:MTA1-A and MTA1-B:HDAC1:RBBP4 were concentrated (1 to 5 mg/ml) in buffer E immediately before analysis. Data were collected on the samples using a Pilatus2M detector (Dectris, CH) at a sample-detector distance of 4014 mm at 12.4 keV at the Diamond B21 beamline (UK). The scattering data was collected to provide a q range of 0.0038-0.42 Å-1, where q is the magnitude of the scattering vector, using a flux of c.1011 photons per second. The samples and matching buffer solutions were exposed to X-rays 30 times in 5s bursts at 25°C. Examination of the data suggested there was no evidence of radiation damage. The lowest concentration datasets (1 mg/ml) were used for analysis using the ATSAS suite of software (Petoukhov et al., 2012) and ScÅtter for basic analysis of the SAXS datasets (BioIsis.net). The radius-of-gyration (Rg) was calculated from Guinier plots and these values were in good agreement with the Rg calculated from the second moment of the P(r) function. The maximum dimension of the scattering molecular species (Dmax) was estimated from the P(r) curve and again these values were favourable comparable to those calculated using the program GNOM (Svergun, 1992). Theoretical scattering profiles were calculated from the crystal structure of HDAC1:MTA1 (Millard et al., 2013) and combined crystal structures of HDAC1:MTA1 and MTA1-R1:RBBP4 and compared to the experimental data using FoXS (Schneidman-Duhovny et al., 2010). Thirteen ab initio dummy atom models were generated using the programme DAMMIF (Franke and Svergun, 2009) and were superposed, merged and filtered using the programme DAMAVER (Volkov and Svergun, 2003).
Chemical crosslinking
Request a detailed protocolGel filtrated MTA1-B:HDAC1:RBBP4 complex was buffer exchanged into 50 mM HEPES (pH 7.5), 50 mM potassium acetate, diluted to 0.5 mg/ml, and the isotopically labelled crosslinker CBDPSS-H8/D8 (CyanurBiotinDimercaptoPropionylSulfoSuccinimide, Creative Molecules Inc.) (Petrotchenko et al., 2011) was added to a final concentration of 0.7 mM. After incubation at 30°C for 30 min the reaction was stopped by addition of 0.5 M NH4HCO3 to a final concentration of 40 mM. The protein was analysed by SDS-PAGE and protein bands corresponding to the crosslinked-dimeric complex were excised from the gel. The sample was reduced with 10 mM DTT, alkylated with 100 mM iodoacetamide and digested with trypsin.
LC-MS/MS was carried out as described previously (Alam et al., 2015). Raw data files were converted to. mzXML format using the ProteoWizard msconvert toolkit (Chambers et al., 2012) and cross-linked peptides were identified using the xQuest/xProphet (Leitner et al., 2014) pipeline with appropriate parameters defined for the CBDPSS isotopically labelled crosslinker. For crosslinks to be considered valid the xQuest Id-Score was required to exceed 14.5, and on inspection of the MS/MS spectra a minimum of either four fragment ions per peptide or three consecutive fragment ions per peptide were required to match.
EM sample preparation
Request a detailed protocolGel filtrated MTA1-B (162-546):HDAC1:RBBP4 was prepared for EM analysis by using GraFIX (Kastner et al., 2007). A 5-25% sucrose gradient with 0-1% glutaraldehyde in 20 mM HEPES/KOH (pH 7.5), 40 mM NaCl was prepared using a Gradient Master IP (BIOCOMP) with a SW60 rotor. The protein complex was added directly on top of the gradient and centrifuged for 15 hr at 166400g in a swing-out rotor. The gradient was manually fractionated into 175 μl fractions and fractions containing monodisperse complex were pooled. The sucrose was removed and cross linking stopped by buffer exchange in a centrifugal filter concentrator (Millipore, Amicon, Ultra-0.5, 10 kDa cut-off) using 20 mM Tris/HCl (pH 7.5), 40 mM NaCl.
EM data collection
Request a detailed protocolNegative stain grids were prepared by glow-discharging carbon coated copper 300 mesh grids (Agar Scientific) at 10 mA for 30 s. The protein complex was diluted to 0.1 mg/ml and 5 μl was applied to the grid. The protein was allowed to absorb for 1 min and blotted to remove excess liquid. The grid was then stained with 2% w/v uranyl acetate. Grids were imaged using a Jeol 2010F TEM operating at 200 kV fitted with a Gatan UltraScan™ 4000 CCD camera with a 15 μm pixel size. 308 micrographs were collected at various defocus values between 0.5 µm and 5 µm, each micrograph contained 20 – 90 particles.
EM image processing
Request a detailed protocol17,841 particles were semi-automatically picked using the EMAN2 e2boxer.py swarm function and extracted using a 224 × 224 pixel box size. Reference-free 2D class averages were generated, with c.100 – 200 particles per class average using e2refine2d.py (Tang et al., 2007). A 60 Å filtered model of the complex was generated based on the crystal structures of HDAC1:MTA1 and MTA1:RBBP4 fitted to the SAXS and crosslinking data, refined against the 17,841 particle dataset, and a model was generated with C1 symmetry using e2refine_easy.py. Resolution of refined model was 19 Å using a FSC criterion cutoff of 0.143.
Peptide binding assays
Request a detailed protocolGel filtrated Flag-RBBP4 and Flag-MTA1-R1-:RBBP4 proteins were diluted to 200 nM in 5 ml TTBS (10 mM Tris-HCl (pH 7.4), 0.05% Tween 20 and 150 mM NaCl) and applied to separate MODified histone peptide arrays (Active Motif) containing 384 unique histone modification combinations. The arrays were washed and protein detected using an anti-Flag antibody according to the manufacture’s protocol. Data from each array was analysed using the commercially available software (Active Motif).
Data availability
-
Structure of the Human RBBP4:MTA1(464-546) complexPublicly available at RCSB Protein Data Bank (accession no. 5fxy).
-
Structure of the core NuRD complex (MTA1:HDAC1:RBBP4)Publicly available at EMData Bank (accession no. EMD-3399).
-
The structure of HDAC1 in complex with the dimeric ELM2-SANT domain of MTA1 from the NuRD complexPublicly available at RCSB Protein Data Bank (accession no. 4bkx).
References
-
The NuRD architectureCellular and Molecular Life Sciences 70:3513–3524.https://doi.org/10.1007/s00018-012-1256-2
-
Insight into the architecture of the NuRD complex: structure of the RbAp48-MTA1 subcomplexThe Journal of Biological Chemistry 289:21844–21855.https://doi.org/10.1074/jbc.M114.558940
-
Chemoproteomics profiling of HDAC inhibitors reveals selective targeting of HDAC complexesNature Biotechnology 29:255–265.https://doi.org/10.1038/nbt.1759
-
A cross-platform toolkit for mass spectrometry and proteomicsNature Biotechnology 30:918–920.https://doi.org/10.1038/nbt.2377
-
The human Mi-2/NuRD complex and gene regulationOncogene 26:5433–5438.https://doi.org/10.1038/sj.onc.1210611
-
How good are my data and what is the resolution?Acta Crystallographica Section D Biological Crystallography 69:1204–1214.https://doi.org/10.1107/S0907444913000061
-
Histone deacetylases and their inhibitors in cancer, neurological diseases and immune disordersNature Reviews. Drug Discovery 13:673–691.https://doi.org/10.1038/nrd4360
-
DAMMIF , a program for rapid ab-initio shape determination in small-angle scatteringJournal of Applied Crystallography 42:342–346.https://doi.org/10.1107/S0021889809000338
-
A core SMRT corepressor complex containing HDAC3 and TBL1, a WD40-repeat protein linked to deafnessGenes & Development 14:1048–1057.
-
Stable histone deacetylase complexes distinguished by the presence of SANT domain proteins CoREST/kiaa0071 and Mta-L1The Journal of Biological Chemistry 276:6817–6824.https://doi.org/10.1074/jbc.M007372200
-
The physiological roles of histone deacetylase (HDAC) 1 and 2: complex co-stars with multiple leading partsBiochemical Society Transactions 41:741–749.https://doi.org/10.1042/BST20130010
-
Cancer biology and NuRD: a multifaceted chromatin remodelling complexNature Reviews Cancer 11:588–596.https://doi.org/10.1038/nrc3091
-
The integration of macromolecular diffraction dataActa Cryst D62:481–5710.https://doi.org/10.1107/s0907444905039107
-
Metastasis tumor antigens, an emerging family of multifaceted master coregulatorsThe Journal of Biological Chemistry 282:1529–1533.https://doi.org/10.1074/jbc.R600029200
-
Histone deacetylase inhibitors: Potential in cancer therapyJournal of Cellular Biochemistry 107:600–608.https://doi.org/10.1002/jcb.22185
-
Phaser crystallographic softwareJournal of Applied Crystallography 40:658–674.https://doi.org/10.1107/S0021889807021206
-
Histone deacetylases: structural determinants of inhibitor selectivityDrug Discovery Today 20:718–735.https://doi.org/10.1016/j.drudis.2015.01.007
-
Towards an understanding of the structure and function of MTA1Cancer Metastasis Reviews 33:857–867.https://doi.org/10.1007/s10555-014-9513-5
-
REFMAC 5 for the refinement of macromolecular crystal structuresActa Crystallographica Section D Biological Crystallography 67:355–367.https://doi.org/10.1107/S0907444911001314
-
BookTransient Expression in HEK 293 Cells: An Alternative to E. Coli for the Production of Secreted and Intracellular Mammalian ProteinsInsoluble Proteins, Methods in Molecular BiologyGarcía-Fruitós E, editors. New York, NY: Springer New York.https://doi.org/10.1007/978-1-4939-2205-5_11
-
Structural basis for the assembly of the SMRT/NCoR core transcriptional repression machineryNature Structural & Molecular Biology 18:177–184.https://doi.org/10.1038/nsmb.1983
-
New developments in the ATSAS program package for small-angle scattering data analysisJournal of Applied Crystallography 45:342–350.https://doi.org/10.1107/S0021889812007662
-
An isotopically coded CID-cleavable biotinylated cross-linker for structural proteomicsMolecular & Cellular Proteomics 10:M110.001420.https://doi.org/10.1074/mcp.M110.001420
-
Recombinant protein expression for structural biology in HEK 293F suspension cells: A novel and accessible approachJournal of Visualized Experiments 31:593–605.https://doi.org/10.3791/51897
-
The zinc finger and C-terminal domains of MTA proteins are required for FOG-2-mediated transcriptional repression via the NuRD complexJournal of Molecular and Cellular Cardiology 44:352–360.https://doi.org/10.1016/j.yjmcc.2007.10.023
-
FoXS: a web server for rapid computation and fitting of SAXS profilesNucleic Acids Research 38:W540–W544.https://doi.org/10.1093/nar/gkq461
-
Role of MTA1 in cancer progression and metastasisCancer Metastasis Reviews 33:879–889.https://doi.org/10.1007/s10555-014-9515-3
-
Structural basis of histone H4 recognition by p55Genes & Development 22:1313–1318.https://doi.org/10.1101/gad.1653308
-
Determination of the regularization parameter in indirect-transform methods using perceptual criteriaJournal of Applied Crystallography 25:495–503.https://doi.org/10.1107/S0021889892001663
-
EMAN2: an extensible image processing suite for electron microscopyJournal of Structural Biology 157:38–46.https://doi.org/10.1016/j.jsb.2006.05.009
-
A novel candidate metastasis-associated gene, mta1, differentially expressed in highly metastatic mammary adenocarcinoma cell lines. cDNA cloning, expression, and protein analysesThe Journal of Biological Chemistry 269:22958–22963.
-
50 years of protein acetylation: from gene regulation to epigenetics, metabolism and beyondNature Reviews Molecular Cell Biology 16:258–264.https://doi.org/10.1038/nrm3931
-
Functional analysis of the SIN3-histone deacetylase RPD3-RbAp48-histone H4 connection in the Xenopus oocyteMolecular and Cellular Biology 19:5847–5860.https://doi.org/10.1128/mcb.19.9.5847
-
Uniqueness of ab initio shape determination in small-angle scatteringJournal of Applied Crystallography 36:860–864.https://doi.org/10.1107/S0021889803000268
-
The histone deacetylase-3 complex contains nuclear receptor corepressorsProceedings of the National Academy of Sciences of the United States of America 97:7202–7207.https://doi.org/10.1073/pnas.97.13.7202
-
Structure and function of WD40 domain proteinsProtein & Cell 2:202–214.https://doi.org/10.1007/s13238-011-1018-1
-
Identification and characterization of the variants of metastasis-associated protein 1 generated following alternative splicingBiochimica Et Biophysica Acta - Gene Structure and Expression 1732:8–14.https://doi.org/10.1016/j.bbaexp.2005.12.001
-
Structural plasticity of histones H3-H4 facilitates their allosteric exchange between RbAp48 and ASF1Nature Structural & Molecular Biology 20:29–35.https://doi.org/10.1038/nsmb.2446
Article and author information
Author details
Funding
Wellcome Trust (WT100237)
- John WR Schwabe
Biotechnology and Biological Sciences Research Council (BB/J009598/1)
- John WR Schwabe
Royal Society (Wolfson Research Merit Award)
- John WR Schwabe
Wellcome Trust (055663/Z/98/Z)
- Corinne J Smith
Biotechnology and Biological Sciences Research Council (BB/K003461/1)
- Kyle Morris
- Corinne J Smith
The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.
Acknowledgements
We would like to thank Xiaowen Yang (PROTEX) for cloning all the expression constructs used in the study. We are grateful to beamline scientists Takashi Tomizaki (PX1, SLS), James Doutch (B21, Diamond) and Neil Paterson (I24, Diamond) for their help in screening crystals, collecting SAXS and X-ray data respectively. We would also like to thank Khushwant Sidhu for assistance with installing and running ProteoWizard msconvert and xQuest/xProphet software. We thank Ian Hands-Portman for technical support with electron microscopy and the Wellcome Trust for generous support (055663/Z/98/Z) to the Imaging Suite at The University of Warwick. CJS and KM thank BBSRC (BB/K003461/1) for support. JWRS is supported by a Senior Investigator Award (WT100237) from the Wellcome Trust and a Biotechnology and Biological Sciences Research Council Project Grant (BB/J009598/1). JWRS is a Royal Society Wolfson Research Merit Award Holder.
Copyright
© 2016, Millard et al.
This article is distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use and redistribution provided that the original author and source are credited.
Metrics
-
- 7,034
- views
-
- 1,326
- downloads
-
- 112
- citations
Views, downloads and citations are aggregated across all versions of this paper published by eLife.
Download links
Downloads (link to download the article as PDF)
Open citations (links to open the citations from this article in various online reference manager services)
Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)
Further reading
-
- Biochemistry and Chemical Biology
- Immunology and Inflammation
Both endogenous antibodies and a subset of antibody therapeutics engage Fc gamma receptor (FcγR)IIIa/CD16a to stimulate a protective immune response. Increasing the FcγRIIIa/IgG1 interaction improves the immune response and thus represents a strategy to improve therapeutic efficacy. FcγRIIIa is a heavily glycosylated receptor and glycan composition affects antibody-binding affinity. Though our laboratory previously demonstrated that natural killer (NK) cell N-glycan composition affected the potency of one key protective mechanism, antibody-dependent cell-mediated cytotoxicity (ADCC), it was unclear if this effect was due to FcγRIIIa glycosylation. Furthermore, the structural mechanism linking glycan composition to affinity and cellular activation remained undescribed. To define the role of individual amino acid and N-glycan residues, we measured affinity using multiple FcγRIIIa glycoforms. We observed stepwise affinity increases with each glycan truncation step, with the most severely truncated glycoform displaying the highest affinity. Removing the N162 glycan demonstrated its predominant role in regulating antibody-binding affinity, in contrast to four other FcγRIIIa N-glycans. We next evaluated the impact of the N162 glycan on NK cell ADCC. NK cells expressing the FcγRIIIa V158 allotype exhibited increased ADCC following kifunensine treatment to limit N-glycan processing. Notably, an increase was not observed with cells expressing the FcγRIIIa V158 S164A variant that lacks N162 glycosylation, indicating that the N162 glycan is required for increased NK cell ADCC. To gain structural insight into the mechanisms of N162 regulation, we applied a novel protein isotope labeling approach in combination with solution NMR spectroscopy. FG loop residues proximal to the N162 glycosylation site showed large chemical shift perturbations following glycan truncation. These data support a model for the regulation of FcγRIIIa affinity and NK cell ADCC whereby composition of the N162 glycan stabilizes the FG loop and thus the antibody-binding site.
-
- Biochemistry and Chemical Biology
- Cell Biology
DYRK1A, a ubiquitously expressed kinase, is linked to the dominant intellectual developmental disorder, microcephaly, and Down syndrome in humans. It regulates numerous cellular processes such as cell cycle, vesicle trafficking, and microtubule assembly. DYRK1A is a critical regulator of organ growth; however, how it regulates organ growth is not fully understood. Here, we show that the knockdown of DYRK1A in mammalian cells results in reduced cell size, which depends on mTORC1. Using proteomic approaches, we found that DYRK1A interacts with the tuberous sclerosis complex (TSC) proteins, namely TSC1 and TSC2, which negatively regulate mTORC1 activation. Furthermore, we show that DYRK1A phosphorylates TSC2 at T1462, a modification known to inhibit TSC activity and promote mTORC1 activity. We also found that the reduced cell growth upon knockdown of DYRK1A can be rescued by overexpression of RHEB, an activator of mTORC1. Our findings suggest that DYRK1A inhibits TSC complex activity through inhibitory phosphorylation on TSC2, thereby promoting mTORC1 activity. Furthermore, using the Drosophila neuromuscular junction as a model, we show that the mnb, the fly homologs of DYRK1A, is rescued by RHEB overexpression, suggesting a conserved role of DYRK1A in TORC1 regulation.